Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 1999;54:900-904; doi:10.1136/thx.54.10.900
Copyright © 1999 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 1999;54:900-904 ( October )

A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma

Wojciech Wasiak, Miroslaw Szmidt

IInd Department of Tuberculosis and Lung Diseases, Institute of Tuberculosis and Lung Disease in Warsaw, 181 Okólna Str., 91-520 Lódz, Poland

Correspondence to: Dr M Szmidt.

Received 28 September 1998; Returned to authors 11 February 1999; Revised version received 2 June 1999; Accepted for publication 23 June 1999

BACKGROUND---Prostaglandins of the E series and misoprostol (a stable analogue of prostaglandin E1) prevent bronchoconstriction following aspirin ingestion or inhalation in subjects with aspirin sensitive asthma. A study was undertaken to investigate the influence of misoprostol on the course of aspirin induced asthma.
METHODS---A double blind, crossover, randomised, placebo controlled study was performed in 17 patients with aspirin sensitive asthma (13 women) aged 26-68 years. All subjects had aspirin sensitivity confirmed by means of oral aspirin or inhaled lysine aspirin challenge. Misoprostol (Cytotec, Searle, 800 or 1600 µg daily according to individual tolerance) or placebo were administered over a period of six weeks. Morning and evening peak expiratory flow rate (PEFR), beta 2 agonist use, asthma and rhinitis severity scores, and defaecation score were measured daily. At the beginning and end of each treatment period spirometric tests were performed and blood was taken for eosinophil count. Eight subjects took misoprostol at a dose of 800 µg and nine subjects at a dose of 1600 µg daily.
RESULTS---No differences were seen in asthma control between misoprostol and placebo except for the rhinorrhoea score which was lower on misoprostol during the period of the study.
CONCLUSION---Misoprostol in a daily dose of 800 or 1600 µg does not significantly improve asthma control in subjects with aspirin sensitive asthma.


Keywords: aspirin sensitive asthma; prostaglandin E1; misoprostol


© 1999 by Thorax

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs